Filings/ZYDUSLIFE/IR

ZYDUS LIFESCIENCES LIMITED IR

press release

Zydus Announces Completion of Phase III trials of Saroglitazar Magnesium in Type 2 Diabetes Mellitus - 02/08/2019

Source document

Issuer site
Loading document…
Zydus Announces Completion of Phase III trials of Saroglitazar Magnesium in Type 2 Diabetes Mellitus - 02/08/2019 — ZYDUS LIFESCIENCES LIMITED